Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
language:"Undetermined"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=language%3A%22Undetermined%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (234)
1
A Fabry Disease Gene Therapy Study : A Phase 1/2, Baseline-controlled, Non-randomised, Open-label, Single-ascending Dose Study of a Novel Adeno-associated Viral Vector (FLT190) in Patients With Fabry disease - MARVEL1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A Fabry Disease Gene Therapy Study : A Phase 1/2, Baseline-controlled, Non-randomised, Open-label, Single-ascending Dose Study of a Novel Adeno-associated Viral Vector (FLT190) in Patients With Fabry disease - MARVEL1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Phase I trial, HMR code: 22-016 : Phase I trial, HMR code: 22-016 [The full scientific title will be published within 30 months after the end of the trial]
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Phase I trial HMR code: 22-014 : Phase I trial HMR code: 22-014 [The full scientific title will be published within 30 months after the end of the trial]
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Phase I trial, HMR code: 22-016 : Phase I trial, HMR code: 22-016 [The full scientific title will be published within 30 months after the end of the trial]
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Phase I trial HMR code: 22-014 : Phase I trial HMR code: 22-014 [The full scientific title will be published within 30 months after the end of the trial]
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
PRIMALVAC : Phase Ia/Ib, randomized, double blinded, dose escalation trial to evaluate the safety and immunogenicity of three vaccinations with the recombinant VAR2CSA protein, a gestational malaria candidate vaccine (PRIMVAC vaccine), formulated with Alhydrogel ® or GLA-SE as adjuvants in healthy adults: European malaria-naïve and African living in malaria-endemic region
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Fractionated microneedle radiofrequency versus botuinum toxin A in primary axillary hyperhidrosis : Efficacy and safety of fractionated microneedle radiofrequency versus botuinum toxin A in primary axillary hyperhidrosis: A randomized controlled clinical trial.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
CAPRISA 012A : A Phase | Study to determine the Safety and Pharmacokinetics of theHuman monoclonal Antibodies, VRC07-523LS and PGT121 administered subcutaneously to HIV negative Adults in South Africa
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
ETVAX : A Phase 1 age descending placebo controlled clinical trial to examine the safety, tolerability, and immunogenicity of an oral inactivated ETEC Vaccine (ETVAX®) in healthy adults and children in Zambia.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Sprache: Unbestimmt
Medienart
234
Aufsätze
234
E-Artikel
234
E-Ressourcen
Zeitschriftentitel
234
WHO International Clinical Trials Registry Plat...
Thema
234
610
Phase: Phase 1
218
Study Type: Interventional
76
Recruitment Status: Not yet recruiting
68
Recruitment Status: Completed
34
Recruitment Status: Authorised-recruitment may ...
34
Recruitment Status: Recruiting
6
Medical Condition: ;Not Applicable
6
Medical Condition: HIV/AIDS;HIV/AIDS
6
Medical Condition: Healthy volunteers Not Appli...
6
Medical Condition: The sponsor has confirmed th...
6
Recruitment Status: Closed to Recruitment of Pa...
6
Study Type: Observational
4
Medical Condition: Fabry disease MedDRA version...
4
Medical Condition: Hemophilia A MedDRA version:...
4
Medical Condition: Relapsed/refractory acute ly...
4
Medical Condition: Small Cell Lung Cancer MedDR...
4
Medical Condition: Synovial sarcoma, Non-small ...
4
Medical Condition: Type 1 diabetes MedDRA versi...
4
Study Type: BA/BE
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
174
2020-
60
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...